Skip to main content

Statement - High Court ruling on PrEP

  • By Gemma Kappala-R...

London Councils' response to the High Court judgement handed down today regarding the commissioning of Pre-Exposure Prophylaxis (PrEP). 

Cllr Teresa O’Neill OBE, London Councils’ Executive member for health, said:

“We are delighted that the High Court has ruled that NHS England does have the power to commission PrEP as part of its broader preventative role and in line with its provision of PEP, as we have maintained all along. 
 
“We hope the NHS now focusses on making PrEP available as part of local prevention programmes as soon as possible.
 
“London boroughs are committed to playing their part in HIV prevention using the fullest range of options and this must include being able to work with NHS England to offer PrEP, as well as promoting HIV testing and condom use. We look forward to getting on with the important task of reducing HIV in London in partnership with the NHS and the voluntary sector.”

ENDS

Notes to editors:

1.         PrEP (Pre-Exposure Prophylaxis) is the use of an anti-retroviral drug (emtricitabine/tenofovir disoproxil fumarate - brand name Truvada) which may be prescribed to HIV negative people who are at high risk of contracting HIV. Using PrEP can prevent them from becoming infected. PEP (Post-Exposure Prophylaxis) is a treatment that can prevent HIV infection after the virus has entered a person's body.